Church & Dwight Co Inc Q4 2024 Earnings Call and Analyst Day Summary

The following is excerpted from the question-and-answer section of the transcript.

Question: Rupesh Parikh - Oppenheimer & Co., Inc. - Analyst : Okay. So maybe just starting with the vitamin business, a lot of enthusiasm on the innovation. And I know -- I think, you ended the year with a double-digit decline. So how are you thinking about the vitamin business from the sales perspective this year? Richard Dierker - Church & Dwight Co Inc - Chief Financial Officer, Executive Vice President, Head of Business Operations Yes. So the vitamin business is one where -- look, like I said in the comments, we really did break glass. We're moving with -- these aren't little I innovations, these are big I innovations in our opinion. So we're going to put the whole full force of the company behind that to long them the right way. Our new CMO, Stacey's right -- working with our leader, Bruce, to really make sure that we're telling the consumer the real core benefit again. So look, it's -- do we think the business is likely going to decline a little bit for a little longer? Yes, we do. But what we want to see is an inflection point. And these innovations are going to help give us that confidence for an inflection point.